In Vivo investigation of radiolabeled Bevacizumab in healthy rat tissues

AUTOR(ES)

Demir, Ilknur, Muftuler, Fazilet Zumrut Biber, Unak, Perihan, Acar, Cigdem

FONTE

Brazilian Archives of Biology and Technology

DATA DE PUBLICAÇÃO

2011-02

RESUMO

In this study, BevMab was conjugated with the bifunctional chelating agent [diethylenetriamine pentaacetic acid (DTPA)] and the product (BevMab-DTPA) was labeled with 99mTc using stannous chloride reducing method. The quality control studies of radiolabeled compound (99mTc-BevMab-DTPA) were done with Thin Layer Radio Chromatography (TLRC) and High Performance Liquid Radio Chromatography (HPLRC) methods (% 95 <) to confirm the labeling efficiency. High radiochemical yield [98.07 % ± 2.17 (n = 13)] was obtained by TLRC method. Biodistribution studies of 99mTc labeled BevMab-DTPA was run on healthy female and male Albino Wistar rats. The distribution figures demonstrated that the radiolabeled compound was eliminated through the kidneys and accumulated in urinary bladder. The values of the BevMab-DTPA uptakes were similar in heart, blood, liver and spleen in both sexes.

Documentos Relacionados

• Effects of exercise training on in vivo insulin action in individual tissues of the rat.
• Bystander effect produced by radiolabeled tumor cells in vivo
• Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat
• Glomerular filtration is reduced by high tidal volume ventilation in an in vivo healthy rat model
• Heavy metals investigation in bovine tissues in Brazil